Genome-wide association study reveals a polymorphism in the podocyte receptor RANK for the decline of renal function in coronary patients

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Leiherer, Andreas ^a,c,d   Muendlein, Axel ^a   Rein, Philipp ^a,b   Saely, Christoph H ^a,b,c   Kinz, Elena ^a,c   Vonbank, Alexander ^a,b   Fraunberger, Peter ^c,d   Drexel, Heinz ^a,b,c,e  

^a Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^b Feldkirch Academic Teaching Hospital Vorarlberg Institute for Vascular Investigation and Treatment   (Austria)

^c PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^d Medical Central Laboratory   (Austria)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; INTRON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; RANK GENE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; COMPLICATION; GENETICS; KIDNEY DISEASES; MIDDLE AGED; PATHOLOGY; PODOCYTE; RISK FACTOR;

AGED; CORONARY ARTERY DISEASE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PODOCYTES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RISK FACTORS;

EID: 84918495678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114240     Document Type: Article

References (43)

1. Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int., 71: 1205-1214.
2. Koettgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M et al. (2010) New loci associated with kidney function and chronic kidney disease. Nat.Genet, 42: 376-384.
3. Koettgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R et al. (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat.Genet, 41: 712-717.
4. Rein P, Saely CH, Vonbank A, Boehnel C, Drexel H (2014) Usefulness of serial decline of kidney function to predict mortality and cardiovascular events in patients undergoing coronary angiography. Am.J.Cardiol, 113: 215-221.
5. Al Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR et al. (2010) Rate of kidney function decline associates with mortality. J.Am.Soc.Nephrol, 21: 1961-1969.
6. Liu CT, Garnaas MK, Tin A, Kottgen A, Franceschini N et al. (2011) Genetic association for renal traits among participants of African ancestry reveals new loci for renal function0. PLoS.Genet, 7: e1002264.
7. Chambers JC, Zhang W, Lord GM, van der HP, Lawlor DA et al. (2010) Genetic loci influencing kidney function and chronic kidney disease. Nat.Genet, 42: 373-375.
8. Muendlein A, Stark N, Rein P, Saely CH, Geller-Rhomberg S et al. (2012) Are AHSG polymorphisms directly associated with coronary atherosclerosis? Clin.Chim.Acta, 413: 287-290.
9. Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R (2010) Targeting podocyte-associated diseases. Adv.Drug Deliv.Rev., 62: 1325-1336.
10. Abrahamson DR (1987) Structure and development of the glomerular capillary wall and basement membrane. Am.J.Physiol, 253: F783-F794.
11. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 390: 175-179.
12. Bharti AC, Aggarwal BB (2004) Ranking the role of RANK ligand in apoptosis. Apoptosis., 9: 677-690.
13. Liu S, Shi W, Xiao H, Liang X, Deng C et al. (2012) Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury. PLoS.One, 7: e41331.
14. Robbins J (2001) KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol.Ther., 90: 1-19.
15. Gilling M, Rasmussen HB, Calloe K, Sequeira AF, Baretto M et al. (2013) Dysfunction of the Heteromeric KV7.3/KV7.5 Potassium Channel is Associated with Autism Spectrum Disorders. Front Genet., 4: 54.
16. Mogensen MS, Scheibye-Alsing K, Karlskov-Mortensen P, Proschowsky HF, Jensen VF et al. (2012) Validation of genome-wide intervertebral disk calcification associations in dachshund and further investigation of the chromosome 12 susceptibility locus. Front Genet., 3: 225.
17. Verhoeven VJ, Hysi PG, Wojciechowski R, Fan Q, Guggenheim JA et al. (2013) Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat.Genet., 45: 314-318.
18. Smeets DF, Scheres JM, Hustinx TW (1986) The most common fragile site in man is 3p14. Hum.Genet., 72: 215-220.
19. Okumura H, Ishii H, Pichiorri F, Croce CM, Mori M et al. (2009) Fragile gene product, Fhit, in oxidative and replicative stress responses. Cancer Sci., 100: 1145-1150.
20. Hadaczek P, Siprashvili Z, Markiewski M, Domagala W, Druck T et al. (1998) Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res., 58: 2946-2951.
21. Gayrard N, Cacheux V, Iborra F, Mourad G, Argiles A (2008) Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation. Arch.Pathol.Lab Med., 132: 965-973.
22. Toma MI, Grosser M, Herr A, Aust DE, Meye A et al. (2008) Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array. Neoplasia., 10: 634-642.
23. Moore LE, Jaeger E, Nickerson ML, Brennan P, De Vries S et al. (2012) Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation. Oncogenesis., 1: e14.
24. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S et al. (1979) Hereditary renal-cell carcinoma associated with a chromosomal translocation. N.Engl.J.Med., 301: 592-595.
25. Anglard P, Tory K, Brauch H, Weiss GH, Latif F et al. (1991) Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res., 51: 1071-1077.
26. Strefford JC, Stasevich I, Lane TM, Lu YJ, Oliver T et al. (2005) A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma. Cancer Genet.Cytogenet., 159: 1-9.
27. Rein P, Saely CH, Muendlein A, Vonbank A, Drexel H (2010) Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic disease. Atherosclerosis, 211: 348-352.
28. Liu Y, Shanahan CM (2011) Signalling pathways and vascular calcification. Front Biosci.(Landmark.Ed), 16: 1302-1314.
29. Malliga DE, Wagner D, Fahrleitner-Pammer A (2011) The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. Wien.Med.Wochenschr., 161: 565-570.
30. Ndip A, Wilkinson FL, Jude EB, Boulton AJ, Alexander MY (2014) RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy. Diabetologia.
31. Wu M, Rementer C, Giachelli CM (2013) Vascular calcification: an update on mechanisms and challenges in treatment. Calcif.Tissue Int., 93: 365-373.
32. Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A et al. (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC.Cardiovasc.Disord., 8: 6.
33. Goek ON, Doring A, Gieger C, Heier M, Koenig W et al. (2012) Serum metabolite concentrations and decreased GFR in the general population. Am.J.Kidney Dis., 60: 197-206.
34. Rebholz CM, Astor BC, Grams ME, Halushka MK, Lazo M et al. (2014) Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study. Nephrol.Dial.Transplant.
35. Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD et al. (2011) Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin.J.Am.Soc.Nephrol., 6: 1963-1972.
36. Drexel H, Amann FW, Beran J, Rentsch K, Candinas R et al. (1994) Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation, 90: 2230-2235.
37. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ et al. (1999) ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J.Am.Coll.Cardiol., 33: 1756-1824.
38. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet.Med., 15: 539-553.
39. Saely CH, Koch L, Schmid F, Marte T, Aczel S et al. (2006) Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients. Eur.J.Clin.Invest, 36: 91-97.
40. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ et al. (2004) Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann.Intern.Med., 141: 929-937.
41. Risch L, Saely CH, Neyer U, Hoefle G, Gouya G et al. (2007) Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care - an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates. Clin.Chim.Acta, 378: 71-77.
42. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C et al. (2012) The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS.Genet., 8: e1002793.
43. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am.J.Hum.Genet., 81: 559-575.